ask="2.50"
ask_size="2000"
average_daily_volume="686764"
bid="1.11"
bid_size="1000"
book_value="1.07"
change="-0.04"
change_from_200_day_moving_average="-1.00"
change_from_50_day_moving_average="-0.21"
change_from_52_week_high="-4.43"
change_From_52_week_low="0.38"
change_in_percent="-2.90%"
close="1.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.01"
ebitda="-16.58M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.28"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.36"
high_52_weeks="5.77"
last_trade_date="1/20/2017"
last_trade_price="1.34"
last_trade_size="300"
last_trade_time="3:59pm"
low="1.28"
low_52_weeks="0.96"
market_capitalization="15.66M"
moving_average_200_day="2.34"
moving_average_50_day="1.55"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.74%"
percent_change_from_50_day_moving_average="-13.46%"
percent_change_from_52_week_high="-76.77%"
percent_change_from_52_week_low="+39.58%"
previous_close="1.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.29"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.04"
stock_exchange="NCM"
symbol="PZRX"
volume="39328"
weeks_range_52="0.96 - 5.77"
